n(1)-methylnicotinamide has been researched along with Venous Thrombosis in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "MNA, however, did not affect venous thrombosis." | 1.34 | 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. ( Adamus, J; Bartus, M; Buczko, W; Chlopicki, S; Gebicki, J; Lomnicka, M; Mogielnicki, A; Swies, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chlopicki, S | 1 |
| Swies, J | 1 |
| Mogielnicki, A | 1 |
| Buczko, W | 1 |
| Bartus, M | 1 |
| Lomnicka, M | 1 |
| Adamus, J | 1 |
| Gebicki, J | 1 |
1 other study available for n(1)-methylnicotinamide and Venous Thrombosis
| Article | Year |
|---|---|
1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
Topics: Animals; Aorta; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Epoprostenol; Fibrinolytic Agents; Hy | 2007 |